- Home
- NRC vs OLMA Comparison
NRC vs OLMA Comparison
Compare NRC & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRC
- OLMA
- Stock Information
- Founded
- NRC 1981
- OLMA 2006
- Country
- NRC United States
- OLMA United States
- Employees
- NRC N/A
- OLMA N/A
- Industry
- NRC Biotechnology: Commercial Physical & Biological Resarch
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- NRC Health Care
- OLMA Health Care
- Exchange
- NRC Nasdaq
- OLMA Nasdaq
- Market Cap
- NRC 310.8M
- OLMA 299.7M
- IPO Year
- NRC N/A
- OLMA 2020
- Fundamental
- Price
- NRC $16.62
- OLMA $4.20
- Analyst Decision
- NRC
- OLMA Strong Buy
- Analyst Count
- NRC 0
- OLMA 4
- Target Price
- NRC N/A
- OLMA $24.50
- AVG Volume (30 Days)
- NRC 85.0K
- OLMA 850.7K
- Earning Date
- NRC 08-05-2025
- OLMA 08-05-2025
- Dividend Yield
- NRC 2.88%
- OLMA N/A
- EPS Growth
- NRC N/A
- OLMA N/A
- EPS
- NRC 1.02
- OLMA N/A
- Revenue
- NRC $141,298,000.00
- OLMA N/A
- Revenue This Year
- NRC N/A
- OLMA N/A
- Revenue Next Year
- NRC N/A
- OLMA N/A
- P/E Ratio
- NRC $16.50
- OLMA N/A
- Revenue Growth
- NRC N/A
- OLMA N/A
- 52 Week Low
- NRC $9.76
- OLMA $2.86
- 52 Week High
- NRC $27.07
- OLMA $16.62
- Technical
- Relative Strength Index (RSI)
- NRC 77.13
- OLMA 43.60
- Support Level
- NRC $15.80
- OLMA $3.90
- Resistance Level
- NRC $17.10
- OLMA $4.29
- Average True Range (ATR)
- NRC 0.56
- OLMA 0.36
- MACD
- NRC 0.16
- OLMA -0.03
- Stochastic Oscillator
- NRC 93.32
- OLMA 19.18
About NRC National Research Corporation (Delaware)
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.